KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Operations: 2010-2025

Historic Cash from Operations for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to -$34.6 million.

  • Opko Health's Cash from Operations rose 55.05% to -$34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.0 million, marking a year-over-year decrease of 11.08%. This contributed to the annual value of -$183.5 million for FY2024, which is 550.74% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Cash from Operations is -$34.6 million, which was up 58.47% from -$83.4 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Cash from Operations ranged from a high of $33.4 million in Q3 2021 and a low of -$83.4 million during Q2 2025.
  • For the 3-year period, Opko Health's Cash from Operations averaged around -$33.1 million, with its median value being -$34.6 million (2025).
  • Its Cash from Operations has fluctuated over the past 5 years, first spiked by 202.71% in 2023, then crashed by 7,142.47% in 2024.
  • Opko Health's Cash from Operations (Quarterly) stood at -$5.6 million in 2021, then tumbled by 460.34% to -$31.6 million in 2022, then dropped by 21.11% to -$38.3 million in 2023, then decreased by 15.97% to -$44.4 million in 2024, then skyrocketed by 55.05% to -$34.6 million in 2025.
  • Its Cash from Operations stands at -$34.6 million for Q3 2025, versus -$83.4 million for Q2 2025 and -$34.6 million for Q1 2025.